POMPANO BEACH, FLORIDA, November 6, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release its third quarter 2023 financial results pre-market on Tuesday, November 14, 2023. BioStem will host a … Continue reading BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023